Literature DB >> 17430997

Vascular abnormalities in primary amyloidosis.

Karen M Modesto1, Angela Dispenzieri, Morie Gertz, Sanderson A Cauduro, Bijoy K Khandheria, James B Seward, Robert Kyle, Christina M Wood, Kent R Bailey, Abdel Jamil Tajik, Fletcher A Miller, Patricia A Pellikka, Theodore P Abraham.   

Abstract

AIMS: Primary amyloidosis (AL) is a systemic disease; however, there is limited information regarding the presence and character of vascular abnormalities. METHODS AND
RESULTS: Validated ultrasound techniques were used to prospectively determine carotid artery intimal-medial thickness (IMT) and brachial artery flow-mediated dilatation (FMD) in 59 consecutive AL patients and 17 age-similar, healthy, asymptomatic volunteers (CON). Carotid IMT was increased in AL when compared with CON (0.07 +/- 0.02 vs. 0.04 +/- 0.01 mm, P < 0.01). Similarly, brachial artery FMD was significantly lower in AL when compared with CON subjects (3 +/- 7 vs. 12 +/- 8%, P < 0.01). Multivariable analysis revealed that AL was associated with larger IMT and lower FMD after controlling for several confounding variables. However, within AL cases, there was not a significant association of cardiac vs. non-cardiac involvement with IMT or FMD (P = 0.1 and 0.2, respectively).
CONCLUSION: AL is associated with abnormal vascular morphology and endothelial dysfunction. Vascular abnormalities do not appear to be related to echocardiographic evidence of cardiac involvement.

Entities:  

Mesh:

Year:  2007        PMID: 17430997     DOI: 10.1093/eurheartj/ehm066

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  THOC5: a novel gene involved in HDL-cholesterol metabolism.

Authors:  Maria Keller; Dorit Schleinitz; Julia Förster; Anke Tönjes; Yvonne Böttcher; Antje Fischer-Rosinsky; Jana Breitfeld; Kerstin Weidle; Nigel W Rayner; Ralph Burkhardt; Beate Enigk; Ines Müller; Jan Halbritter; Moritz Koriath; Andreas Pfeiffer; Knut Krohn; Leif Groop; Joachim Spranger; Michael Stumvoll; Peter Kovacs
Journal:  J Lipid Res       Date:  2013-09-10       Impact factor: 5.922

2.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

3.  Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Authors:  Sharmila Dorbala; Divya Vangala; John Bruyere; Christina Quarta; Jenna Kruger; Robert Padera; Courtney Foster; Michael Hanley; Marcelo F Di Carli; Rodney Falk
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

4.  Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Authors:  Arnt V Kristen; Johannes Rinn; Ute Hegenbart; David Lindenmaier; Corina Merkle; Christoph Röcken; Stefan Hardt; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2014-10-21       Impact factor: 5.460

5.  Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins.

Authors:  Raymond Q Migrino; Seth Truran; David D Gutterman; Daniel A Franco; Megan Bright; Brittany Schlundt; Mitchell Timmons; Angelica Motta; Shane A Phillips; Parameswaran Hari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

Review 6.  [Congenital disorders of lipoprotein metabolism].

Authors:  W März; T B Grammer; G Delgado; M E Kleber
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 7.  Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.

Authors:  Paco E Bravo; Marcelo F Di Carli; Sharmila Dorbala
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

8.  Cardiac amyloidosis responding to bortezomib: case report and review of literature.

Authors:  Edriss Charaf; Said B Iskandar; Ashley Blevins; Bernard Abi-Saleh; Stephen Fahrig
Journal:  Curr Cardiol Rev       Date:  2009-08

9.  Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury.

Authors:  Seth Truran; Volkmar Weissig; Marina Ramirez-Alvarado; Daniel A Franco; Camelia Burciu; Joseph Georges; Shishir Murarka; Winter A Okoth; Sara Schwab; Parameswaran Hari; Raymond Q Migrino
Journal:  J Liposome Res       Date:  2013-11-15       Impact factor: 3.648

10.  Protective role of clusterin in preserving endothelial function in AL amyloidosis.

Authors:  Daniel A Franco; Seth Truran; Camelia Burciu; David D Gutterman; Anthony Maltagliati; Volkmar Weissig; Parameswaran Hari; Raymond Q Migrino
Journal:  Atherosclerosis       Date:  2012-09-01       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.